Adjuvant Capital Management, Llc - Net Worth and Insider Trading
Adjuvant Capital Management, Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Adjuvant Capital Management, Llc owns 1 companies in total, including AN2 Therapeutics Inc (ANTX) .
Insider Ownership Summary of Adjuvant Capital Management, Llc
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ANTX | AN2 Therapeutics Inc | 2022-03-24 | 10 percent owner |
Adjuvant Capital Management, Llc Trading Performance
Adjuvant Capital Management, Llc Ownership Network
Adjuvant Capital Management, Llc Owned Company Details
What does AN2 Therapeutics Inc do?
Who are the key executives at AN2 Therapeutics Inc?
Adjuvant Capital Management, Llc is the 10 percent owner of AN2 Therapeutics Inc. Other key executives at AN2 Therapeutics Inc include 10 percent owner Ra Capital Healthcare Fund Lp , 10 percent owner Adjuvant Global Health Technology Fund De, L.p. , and Chief Strategy Officer Kevin Michael Krause .
AN2 Therapeutics Inc (ANTX) Insider Trades Summary
Over the past 18 months, Adjuvant Capital Management, Llc made no insider transaction in AN2 Therapeutics Inc (ANTX). Other recent insider transactions involving AN2 Therapeutics Inc (ANTX) include a net sale of 223,880 shares made by Kabeer Aziz , a net sale of 223,880 shares made by Adjuvant Global Health Technology Fund De, L.p. , and a net sale of 1,747,316 shares made by Ra Capital Healthcare Fund Lp .
In summary, during the past 3 months, insiders sold 3,525,094 shares of AN2 Therapeutics Inc (ANTX) in total and bought 1,500,000 shares, with a net sale of 2,025,094 shares. During the past 18 months, 4,090,725 shares of AN2 Therapeutics Inc (ANTX) were sold and 3,287,778 shares were bought by its insiders, resulting in a net sale of 802,947 shares.
AN2 Therapeutics Inc (ANTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
AN2 Therapeutics Inc Insider Transactions
Adjuvant Capital Management, Llc Mailing Address
Above is the net worth, insider trading, and ownership report for Adjuvant Capital Management, Llc. You might contact Adjuvant Capital Management, Llc via mailing address: 501 Fifth Avenue, Suite 1404, New York Ny 10017.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
